Related Experiment Video

Updated: Jul 7, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

Treatment of retinopathy of prematurity

David Clark1, K Mandal

  • 1Aintree NHS Hospitals Trust, UK. DAVID.CLARK@aintree.nhs.uk

Early Human Development
|February 19, 2008
PubMed

Insights

Retinopathy of prematurity treatment, including laser photocoagulation, improves outcomes for premature infants. Earlier intervention for high-risk pre-threshold disease offers significantly better results, though further treatments may be needed.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Biology

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants.
  • Current treatments like laser photocoagulation aim to reduce adverse structural and visual outcomes.
  • Despite treatment, significant visual impairment persists in a notable percentage of cases.

Purpose of the Study:

  • To review the efficacy of current treatments for retinopathy of prematurity.
  • To highlight the benefits of early intervention in high-risk pre-threshold ROP.
  • To discuss outcomes and future therapeutic directions for ROP.

Main Methods:

  • Review of landmark studies (CRYO-ROP, ETROP) on ROP treatment.
  • Analysis of outcomes associated with cryotherapy and laser photocoagulation.
  • Discussion of surgical interventions and emerging therapies like anti-VEGF.

Main Results:

  • Laser photocoagulation improves structural and visual outcomes compared to no treatment.
  • Early treatment of type 1 pre-threshold ROP yields significantly better results than threshold treatment.
  • Retinal detachment remains a complication, with variable outcomes from surgical treatments.

Conclusions:

  • Current ablative therapies for ROP offer long-term benefits but do not eliminate visual impairment.
  • Early treatment strategies for high-risk ROP are crucial for improved visual acuity.
  • Anti-VEGF therapies represent a promising future direction for ROP management.

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...